Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02793739 · ClinicalTrials.gov registry record · NA

Hyaluronic Acid Filler for Dorsal Finger Volume Loss

A NA study of Personal Satisfaction, sponsored by Marmur Medical.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02793739: Completed NA study of Personal Satisfaction, sponsored by Marmur Medical.

NCT02793739 is a NA study of Personal Satisfaction that has completed, run by Marmur Medical. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02793739, a NA study of Personal Satisfaction, has completed, sponsored by Marmur Medical.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Fingers are a part of the body that are often subject to increased signs of aging due to physical use, trauma and exposure to the environment. The FDA's recent approval of a dermal filler, calcium hydroxylapatite, in hands has led to increased patient demand for hand fillers which, in turn, has led to the question of rejuvenation of the dorsal fingers. Due to the different anatomy of the fingers than the dorsal hand plus the new demand to improve the entire hand plus the finger area, we aim to characterize the best approach. Youthful fingers are devoid of wrinkles and often have fuller contours thus hiding the "knuckles" (proximal and distal interphalangeal joints). With aging and loss of subcutaneous tissue volume, fingers become wrinkled, look more skeletal, almost emaciated, and joints become much more prominent, all aesthetic features often disliked by patients. By augmenting the volume in the dorsal fingers, it is possible that the visibility of such bony structures will be decreased, wrinkles will become smoother, and a more youthful appearance of the fingers will be restored. There have been no published reports, to these investigators' knowledge, of the use of injectable filler into the dorsal fingers for three-dimensional volume correction. The use of exogenous hyaluronic acid (HA) filler in the fingers would be off-label. Given that HA filler has been used safely and effectively in many areas of three-dimensional volume restoration throughout the body, the investigators believe the HA filler may be used to effectively and safely correct volume loss in the fingers. The investigators hope that this study will present current, state of the art, never before reported technique, safety, efficacy and patient satisfaction of HA filler in this region.

Primary Outcome

At each study visit, the investigator or sub-investigator will collect data regarding efficacy of volume restoration in the dorsal fingers by assessing qualitative changes in volume of the dorsal fingers.

Conditions Studied

Interventions

  • PROCEDURE Hyaluronic acid filler injection

Study Locations (1)

New York

  • Marmur Medical - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-09
Est. Completion 2021-08
Phase NA
Marmur Medical

1 total trials

What the finished NCT02793739 record still lists

NCT02793739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Personal Satisfaction appearing as the primary indexed condition, and to 1 intervention - of which Hyaluronic acid filler injection is the first listed.

NCT02793739 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02793739 about?

NCT02793739 is a clinical study titled "Hyaluronic Acid Filler for Dorsal Finger Volume Loss". Fingers are a part of the body that are often subject to increased signs of aging due to physical use, trauma and exposure to the environment. The FDA's recent approval of a dermal filler, calcium hydroxylapatite, in hands has led to increased patient demand for hand fillers which, in turn, has led ...

What is the current status of trial NCT02793739?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2021-08.

What conditions does trial NCT02793739 study?

This clinical trial studies the following conditions: Personal Satisfaction.

What interventions are being tested in trial NCT02793739?

The interventions under investigation include: Hyaluronic acid filler injection (PROCEDURE).

Who is sponsoring clinical trial NCT02793739?

This trial is sponsored by Marmur Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02793739 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Personal Satisfaction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02793739's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02793739, the US trial registry maintained by the National Library of Medicine. NCT02793739 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.